Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer
Amgen announced the appointment of Robert Bradway as executive vice president and chief financial officer. He will be responsible for Amgen's finance, strategy and investor relations operations. Bradway replaces Richard Nanula, who is leaving the company to pursue other opportunities.
Bradway, 44, joined Amgen in 2006 as vice president, Operations Strategy. Prior to joining the company, he spent 18 years at Morgan Stanley in New York and London, where he was a managing director in investment banking. Bradway led Morgan Stanley's healthcare practice in Europe for several years and also ran the company's European banking department.
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.